Member Info for Ad4you

https://twitter.com/NovacytGroup/status/1404442510445973510

Oh well, hopefully not much longer for GM to confirm.

It looks like Roche are already in partnership with SD Biosensor. Inc on this?

https://www.thesun.co.uk/news/15257917/britain-covid-third-wave-sage-adviser/

https://twitter.com/NovacytGroup/status/1404087442240643076

Have you guy's not run out of hairs to split yet?

https://www.express.co.uk/news/uk/1449064/uk-covid-cases-latest-deaths-boris-johnson-lockdown-announcement-june-21-reopening

https://twitter.com/NovacytGroup/status/1403710944375627777

https://www.which.co.uk/consumer-rights/advice/what-is-alternative-dispute-resolution-adr-alOPl0X2lbsO

Larry - thanks for the update.

I have attached a link from the Gov Website
https://www.gov.uk/government/publications/alternative-dispute-resolution-for-consumers/alternative-dispute-resolution-for-consumers

Thanks Poidster

Thanks Poidster - Are you sensing this through what you have seen/heard at work?

Do you sense whether it will cause us further issues or may have a better outcome?

Porky is this connected to your comment re Saliva Test?

From the R&D RNS 23rd April
Expansion of the genesig® COVID-19 PCR portfolio

Following an emerging need in some countries, Novacyt has launched a CE-IVD genesig® COVID-19 three-gene target test for use with nasopharyngeal, oropharyngeal and saliva sample types. This key extension to the genesig® COVID-19 portfolio, alongside the one-gene and two-gene tests, is expected to be critical for use in airport test and release programmes to and from certain countries.

Thanks Larry

https://www.express.co.uk/news/uk/1448682/Covid-deaths-uk-records-cases-spike-June-21-lockdown-end-Indian-variant-latest

I believe it was mention on here re Novacyt exhibiting at this - can anyone confirm if that is the case?

If so would be the ideal opportunity along with all their other great products to showcase their new LFT - wouldn't it?????????????????/

"MENA's leading medical laboratory exhibition
If you’re looking to find products, make new investments, gain new knowledge or strengthen business ties with the global clinical laboratory market, Medlab Middle East is your central platform for a full-scale industry experience."

https://www.medlabme.com/en/home.html

PathFlow® SARS-CoV-2 Antigen is a professional and home use LFT for the detection of SARS-CoV-2 antigens using non-invasive anterior nasal swab samples to provide a result in approximately 15 minutes. Novacyt has been working with a partner to develop this test, which is able to detect the virus regardless of current known mutations. The Company intends to launch the test as CE-IVD before the end of Q2 2021 and expects it to complement Novacyt's established position in COVID-19 PCR testing. As the market for COVID-19 testing continues to develop, the Directors believe this product could add significant revenues for Novacyt.

# Trades 572
Vol. Sold 219,814
Sold Value £762.31k
Vol. Bought 441,613
Bought Value £2m
PE Ratio -28.994
Earnings -11.961
Dividend 0.00
Yield 0.00%

Wilson - After several goes at refreshing it's now corrected - Gremlins again no doubt!

Is anyone else having issues with this mornings posts being displayed?

Is there a problem with the website or is someone again getting posts removed?

The last post I can see is 08.33am

# Trades 196
Vol. Sold 27,895
Sold Value £97.91k
Vol. Bought 182,169
Bought Value £639.41k
PE Ratio -29.346
Earnings -11.961
Dividend 0.00
Yield 0.00%